This work examined the GSEA database and clinical samples, demonstrating that ACSL3 is markedly overexpressed in NAFLD and HCC tissues, with a positive correlation to disease severity (Li et al., 2024). This evidence concerns the gene ACSL3 and hepatocellular carcinoma.